Overall Technical outlook

Price Summary

On 2025-06-13, MANKIND's stock opened at 2360.1, reached a peak of 2386.7, dropped to 2344.1, and ended 0.9% higher at 2381.3, with a volume of 192182 shares.
The peak price for the stock in the past 52 weeks is 2998.4, with the lowest price being 1990.4.
MANKIND's future price is expected to lie between 2150.0 and 3300.0, with an average expectation of 2789.5881, as per the recommendations of 17 analysts.

Technicals

Support and Resistance: The price of 2381.3 is supported at 2364.55 and faces resistance at 2453.95. This range suggests key levels for MANKIND where the price may stabilize, with 2364.55 acting as a support and 2453.95 as a cap on gains.
MANKIND supportResistance 18151a
Support/Resistance for MANKIND


Aroon: The AROON is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
MANKIND aroon 18151a
Aroon chart for Mankind Pharma Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for MANKIND, with no strong trend emerging.
MANKIND bbands 18151a
Bolinger Bands chart for Mankind Pharma Limited


Parabolic SAR: The PSAR remains bearish, establishing a resistance level that could cap any potential upward trends. This ongoing bearish outlook suggests that the market may continue to face resistance, making it difficult to achieve significant gains for MANKIND.
MANKIND psar 18151a
Parabolic Stop and Reverse chart for Mankind Pharma Limited


Stochastic: The STOCHASTIC is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
MANKIND stoch 18151a
Stochastic chart for Mankind Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
MANKIND trippleSMA 18151a
Tripple SMA chart for Mankind Pharma Limited


When assessing a company's technical performance, such as stock price fluctuations and trading volume, it is crucial to first examine its fundamentals. These fundamentals include financial health, profitability, and growth potential. Additionally, understanding the industry's dynamics, including competitive pressures and market trends, is key to contextualizing the company's performance. By integrating these factors, a more comprehensive and meaningful analysis can be conducted, leading to more informed investment decisions.